BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, Allen PJ, DeMatteo RP, Kingham TP, D'Angelica MI, Jarnagin WR. Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. J Am Coll Surg. 2017;224:906-916. [PMID: 28216422 DOI: 10.1016/j.jamcollsurg.2016.12.058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuza K, Sakata J, Hirose Y, Miura K, Ando T, Katada T, Takizawa K, Kobayashi T, Ichikawa H, Shimada Y, Nagahashi M, Wakai T. Outcome of radical surgery for gallbladder carcinoma according to TNM stage: implications for adjuvant therapeutic strategies. Langenbecks Arch Surg 2021;406:801-11. [PMID: 33398448 DOI: 10.1007/s00423-020-02068-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Choi SY, Kim JH, Park HJ, Han JK. Preoperative CT findings for prediction of resectability in patients with gallbladder cancer. Eur Radiol. 2019;29:6458-6468. [PMID: 31254061 DOI: 10.1007/s00330-019-06323-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Goel M, Gupta AM, Patkar S, Parray AM, Shetty N, Ramaswamy A, Patil P, Chopra S, Ostwal V, Kulkarni S, Engineer R, Mehta S. Towards standardization of management of gallbladder carcinoma with obstructive jaundice: Analysis of 113 cases over 10 years at a single institution. J Surg Oncol 2021;124:572-80. [PMID: 34106475 DOI: 10.1002/jso.26564] [Reference Citation Analysis]
4 Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer – A systematic review. European Journal of Surgical Oncology 2019;45:83-91. [DOI: 10.1016/j.ejso.2018.08.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
5 Abe T. ASO Author Reflections: Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis. Ann Surg Oncol 2018;25:790-1. [PMID: 30315386 DOI: 10.1245/s10434-018-6912-9] [Reference Citation Analysis]
6 Zhang L, Hou C, Xu Z, Wang L, Ling X, Xiu D. Laparoscopic treatment for suspected gallbladder cancer confined to the wall: a 10-year study from a single institution. Chin J Cancer Res. 2018;30:84-92. [PMID: 29545722 DOI: 10.21147/j.issn.1000-9604.2018.01.09] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol 2021;94:20200726. [PMID: 33090880 DOI: 10.1259/bjr.20200726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Patkar S, Chaturvedi A, Goel M, Rangarajan V, Sharma A, Engineer R. Role of positron emission tomography-contrast enhanced computed tomography in locally advanced gallbladder cancer. J Hepatobiliary Pancreat Sci 2020;27:164-70. [PMID: 31945262 DOI: 10.1002/jhbp.712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ozer M, Goksu SY, Sanford NN, Porembka M, Khurshid H, Ahn C, Maxwell MC, Beg MS, Kazmi SM. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer. JAMA Netw Open 2022;5:e2146912. [PMID: 35171262 DOI: 10.1001/jamanetworkopen.2021.46912] [Reference Citation Analysis]
10 Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ, Muiesan P, Isaac J, Marudanayagam R, Mirza DF. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol. 2018;118:477-485. [PMID: 30259519 DOI: 10.1002/jso.25186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
11 Miyamoto R, Ogura T, Takahashi A, Ishida H, Matsudaira S, Amikura K, Suzuki Y, Shimizu S, Kihara A, Kanda H, Kawashima Y. Conversion surgery for initially unresectable advanced biliary tract cancer treated with gemcitabine plus cisplatin combination chemotherapy: a case report and literature review. Int Canc Conf J. [DOI: 10.1007/s13691-022-00545-y] [Reference Citation Analysis]
12 Ji GW, Zhang YD, Zhang H, Zhu FP, Wang K, Xia YX, Zhang YD, Jiang WJ, Li XC, Wang XH. Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology. 2019;290:90-98. [PMID: 30325283 DOI: 10.1148/radiol.2018181408] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 15.0] [Reference Citation Analysis]
13 Cherkassky L, D'Angelica M. Gallbladder Cancer: Managing the Incidental Diagnosis. Surg Oncol Clin N Am 2019;28:619-30. [PMID: 31472909 DOI: 10.1016/j.soc.2019.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 Gupta P, Meghashyam K, Marodia Y, Gupta V, Basher R, Das CK, Yadav TD, Irrinki S, Nada R, Dutta U. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol 2021;46:998-1007. [DOI: 10.1007/s00261-020-02756-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Koppatz H, Takala S, Peltola K, But A, Mäkisalo H, Nordin A, Sallinen V. Gallbladder cancer epidemiology, treatment and survival in Southern Finland - a population-based study. Scand J Gastroenterol 2021;56:929-39. [PMID: 34224306 DOI: 10.1080/00365521.2021.1915373] [Reference Citation Analysis]
16 Cherkassky L, Jarnagin W. Selecting treatment sequence for patients with incidental gallbladder cancer: a neoadjuvant approach versus upfront surgery. Updates Surg 2019;71:217-25. [PMID: 31254234 DOI: 10.1007/s13304-019-00670-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Castelo Branco M, Estevinho F, Correia Pinto J, Honavar M, Raposo C, Silva AC, Sottomayor C. Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease. J Gastrointest Cancer 2019;50:564-7. [PMID: 29292472 DOI: 10.1007/s12029-017-0044-5] [Reference Citation Analysis]
18 Oh MY, Kim H, Choi YJ, Byun Y, Han Y, Kang JS, Sohn H, Lee JM, Kwon W, Jang JY. Conversion surgery for initially unresectable extrahepatic biliary tract cancer. Ann Hepatobiliary Pancreat Surg 2021;25:349-57. [PMID: 34402435 DOI: 10.14701/ahbps.2021.25.3.349] [Reference Citation Analysis]
19 Kingham TP, Aveson VG, Wei AC, Castellanos JA, Allen PJ, Nussbaum DP, Hu Y, D'Angelica MI. Surgical management of biliary malignancy. Curr Probl Surg 2021;58:100854. [PMID: 33531120 DOI: 10.1016/j.cpsurg.2020.100854] [Reference Citation Analysis]
20 Mochizuki T, Abe T, Amano H, Hanada K, Hattori M, Kobayashi T, Nakahara M, Ohdan H, Noriyuki T. Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis. Ann Surg Oncol 2018;25:1699-708. [DOI: 10.1245/s10434-018-6444-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Søreide K, Harrison EM, Wigmore SJ. Research gaps and unanswered questions in gallbladder cancer. HPB 2018;20:685-6. [DOI: 10.1016/j.hpb.2018.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
22 Desai P, Janova H, White JP, Reynoso GV, Hickman HD, Baldridge MT, Urban JF Jr, Stappenbeck TS, Thackray LB, Diamond MS. Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis. Cell 2021;184:1214-1231.e16. [PMID: 33636133 DOI: 10.1016/j.cell.2021.01.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
23 Kamada Y, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Tani M, Sato A, Tani R, Aoyama R, Sasaki Y, Zaima M. Surgical treatment of gallbladder cancer: An eight-year experience in a single center. World J Hepatol 2020; 12(9): 641-660 [PMID: 33033570 DOI: 10.4254/wjh.v12.i9.641] [Reference Citation Analysis]
24 Chaudhari VA, Ostwal V, Patkar S, Sahu A, Toshniwal A, Ramaswamy A, Shetty NS, Shrikhande SV, Goel M. Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications. HPB 2018;20:841-7. [DOI: 10.1016/j.hpb.2018.03.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
25 Naveed S, Qari H, Thau CM, Burasakarn P, Mir AW. Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review. Euroasian J Hepatogastroenterol 2021;11:87-94. [PMID: 34786362 DOI: 10.5005/jp-journals-10018-1348] [Reference Citation Analysis]
26 Hickman L, Contreras C. Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am. 2019;99:337-355. [PMID: 30846038 DOI: 10.1016/j.suc.2018.12.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 12.7] [Reference Citation Analysis]
27 Chaudhary RK, Higuchi R, Yazawa T, Uemura S, Izumo W, Furukawa T, Kiyohara K, Yamamoto M. Surgery in node-positive gallbladder cancer: The implication of an involved superior retro-pancreatic lymph node. Surgery 2019;165:541-7. [PMID: 30348459 DOI: 10.1016/j.surg.2018.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
28 Creasy JM, Goldman DA, Gonen M, Dudeja V, O'Reilly EM, Abou-Alfa GK, Cercek A, Harding JJ, Balachandran VP, Drebin JA, Allen PJ, Kingham TP, D'Angelica MI, Jarnagin WR. Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. HPB (Oxford) 2019;21:1541-51. [PMID: 31027875 DOI: 10.1016/j.hpb.2019.03.370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
29 Patil PA, Lombardo K, Cao W. Immune Microenvironment in Gallbladder Adenocarcinomas. Appl Immunohistochem Mol Morphol 2021;29:557-63. [PMID: 33710123 DOI: 10.1097/PAI.0000000000000922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]